]cyt) in airway smooth muscle (ASM) is a key aspect of airway contractility and can be modulated by inflammation. Mitochondria have tremendous potential for buffering [Ca 2ϩ ]cyt, helping prevent Ca 2ϩ overload, and modulating other intracellular events. Here, compartmentalization of mitochondria to different cellular regions may subserve different roles. In the present study, we examined the role of Ca 2ϩ buffering by mitochondria and mitochondrial Ca 2ϩ transport mechanisms in the regulation of [Ca 2ϩ ]cyt in enzymatically dissociated human ASM cells upon exposure to the proinflammatory cytokines TNF-␣ and IL-13. Cells were loaded simultaneously with fluo-3 AM and rhod-2 AM, and [Ca 2ϩ ]cyt and mitochondrial Ca 2ϩ concentration ([Ca 2ϩ ]mito) were measured, respectively, using real-time two-color fluorescence microscopy in both the perinuclear and distal, perimembranous regions of cells. Histamine induced a rapid increase in both [Ca 2ϩ ]cyt and [Ca 2ϩ ]mito, with a significant delay in the mitochondrial response. Inhibition of the mitochondrial Na ϩ /Ca 2ϩ exchanger (1 M CGP-37157) increased [Ca 2ϩ ]mito responses in perinuclear mitochondria but not distal mitochondria. Inhibition of the mitochondrial uniporter (1 M Ru360) decreased [Ca 2ϩ ]mito responses in perinuclear and distal mitochondria. CGP-37157 and Ru360 significantly enhanced histamine-induced [Ca 2ϩ ]cyt. TNF-␣ and IL-13 both increased [Ca 2ϩ ]cyt, which was associated with decreased [Ca 2ϩ ]mito in the case of TNF-␣ but not IL-13. The effects of TNF-␣ on both [Ca 2ϩ ]cyt and [Ca 2ϩ ]mito were affected by CGP-37157 but not by Ru360. Overall, these data demonstrate that in human ASM cells, mitochondria buffer [Ca 2ϩ ]cyt after agonist stimulation and its enhancement by inflammation. The differential regulation of [Ca 2ϩ ]mito in different parts of ASM cells may serve to locally regulate Ca 2ϩ fluxes from intracellular sources versus the plasma membrane as well as respond to differential energy demands at these sites. We propose that such differential mitochondrial regulation, and its disruption, may play a role in airway hyperreactivity in diseases such as asthma, where [Ca 2ϩ ]cyt is increased.
lung; bronchial smooth muscle; calcium regulation; sarcoplasmic reticulum; inflammation; mitochondrial sodium-calcium exchange; mitochondrial calcium uniporter MITOCHONDRIA have been known for several decades to have a role in Ca 2ϩ sequestration (76, 82) . Metabolism or ATP production could be enhanced by mitochondrial Ca 2ϩ uptake, and perinuclear mitochondria might be involved in shaping nuclear Ca 2ϩ signals (9, 10, 23, 64) . Whether mitochondria contribute to regulate cytosolic Ca 2ϩ concentration ([Ca 2ϩ ] cyt ) is subject to debate (10, 48, 64) .
The importance of defining the role of mitochondrial Ca 2ϩ buffering in human airway smooth muscle (ASM) lies in understanding the mechanisms by which [Ca 2ϩ ] cyt is enhanced in airway diseases such as asthma, which contribute to airway hyperresponsiveness. Mitochondrial dysfunction and some ultrastructural changes in mitochondria (swelling and loss of cristae) have been observed with airway inflammation (1, 39) . In human ASM, mitochondria are present in large numbers (79) , and, interestingly, mitochondrial biogenesis is enhanced in asthma (28) . Whether such changes can contribute to altered Ca 2ϩ homeostasis or other features of asthma, such as airway remodeling, is not known.
Mitochondrial Ca 2ϩ uptake during agonist stimulation has been observed in different cell types (13, 25, 33, 38, 48, 55, 56, 65) and is thought to decrease local Ca 2ϩ gradients for sarcoplasmic reticulum (SR)/endoplasmic reticulum Ca 2ϩ refilling while maintaining or enhancing store-operated Ca 2ϩ entry (SOCE) (24, 37, 41, 45, 50, 81) . Some theoretical models of Ca 2ϩ signaling in smooth muscle that include mitochondria also suggest a role for modulating [Ca 2ϩ ] cyt regulatory mechanisms (66, 67) . In this regard, mitochondria are often located near the SR and plasma membrane (PM), and this physical proximity may be important (25, 33, 63, 69) , especially to buffer locally high levels of Ca 2ϩ during stimulation (27, 53, 56, 57) . These studies raise the question of the relation between the spatial localization of mitochondria and their ability to buffer or release Ca 2ϩ . Recent work has established that mitochondria contain sophisticated Ca 2ϩ uptake and release mechanisms that may alter [Ca 2ϩ ] cyt either globally or in the vicinity of the SR and PM (10, 13, 16, 22, 25, 33, 38, 43, 48, 52, 60, 62, 63, 65, 70) . There is currently little information on these roles for mitochondria in ASM cells.
Several studies have suggested that airway inflammation increases airway contractility by modulating Ca 2ϩ regulatory mechanisms (2-4, 61, 71, 72, 74, 77, 84) . Proinflammatory mediators, including cytokines such as TNF-␣ and IL-13, increase agonist-induced [Ca 2ϩ ] cyt responses in ASM cells (74, 75, 84) . The role of mitochondria in shaping these signals has not been examined. Furthermore, little is known about the effects of inflammation on mitochondrial buffering of [Ca 2ϩ ] cyt in human ASM. In other smooth muscle types, inflammatory cytokines disrupt mitochondria-SR interactions and Ca 2ϩ buffering (64, 65) . Studies have also shown that short-term exposure to TNF-␣ temporary increases basal mitochondrial Ca 2ϩ in the lung endothelium, leading to an increase of mitochondrial ROS generation (19, 51, 68) . A recent study (13) 
MATERIALS AND METHODS
Isolation of human ASM cells. These techniques have been previously described (58, 78) . Briefly, ASM cells were enzymatically dissociated from third-to sixth-generation bronchi of lung samples incidental to patient surgery at Mayo Clinic (approved and considered exempt by the Institutional Review Board of Mayo Clinic). Normal lung areas were identified, and dissected tissues were placed in ice-cold HBSS (Invitrogen, Carlsbad, CA) supplemented with 10 mM HEPES and 2 mM Ca 2ϩ . Under light microscopy, bronchioles were freed of cartilage, the epithelium, and surrounding tissues, and ASM tissue was dissected out. Samples were minced, and cells were dissociated using papain and collagenase with ovomucoid/albumin separation as per the manufacturer's instructions (Worthington Biochemical, Lakewood, NJ). Cell pellets were resuspended and plated in sterile culture flasks or eight-well glass-bottomed Lab-Tek chambers (Nalge Nunc, Rochester, NY). Cells were maintained at 37°C (5% CO2-95% air) using phenol red-free DMEM-F-12 medium (Invitrogen) supplemented with 10% FBS until ϳ80% confluent. Before experiments, cells were washed in PBC (Invitrogen), and medium was changed to DMEM-F-12 lacking serum for 48 h. All experiments were performed in cells from passages 1-3 of subculture. Periodic assessment of the ASM phenotype (smooth muscle actin and myosin and agonist receptors as well as lack of fibroblast markers) was performed. Cell viability was tested by the exclusion of trypan blue.
Real ] in response to histamine (His; 10 M) was observed for the ROI chosen within the mitochondria (region 1, solid line) and not for the ROIs placed in either the cytosol (region 2, dotted line) or near the mitochondria (region 3, dashed line). E and F: MitoTracker greenloaded cells excited at 488 nm showed significant specific fluorescence at 501 nm, corresponding to MitoTracker green (E), whereas excitation of the cells at 568 nm (rhod-2 AM excitation wavelength) did not show significant (above background) fluorescence at 590 nm (F). G and H: similarly, excitation of ASM cells loaded with 2.5 M rhod-2 AM at 488 nm (G; Mitotracker green excitation wavelength) did not result in any nonspecific fluorescence at 501 nm (above background), whereas excitation at 568 nm resulted in specific fluorescence at 590 nm, corresponding to rhod-2 AM (H). Ex, excitation; Em, emission. ]cyt imaging of human ASM cells have been previously described (58, 73, 78) . Cells were visualized using an epifluorescence imaging system (MetaFluor, Universal Imaging, Downingtown, PA) on a Nikon Diaphot inverted microscope (Fryer Instruments, Edina, MN) with a ϫ40/1.3 numerical aperture oilimmersion lens (or a ϫ60/1.3 numerical aperture oil-immersion lens) and a 12-bit Photometric Cascade digital camera system (Roper Scientific, Tucson, AZ). Images were collected at 1 Hz. Cells were initially perfused with 2 mM Ca 2ϩ HBSS, and baseline fluorescence was established. Changes in fluorescence were analyzed by selecting individual software-defined regions of interest (ROIs; 3 ϫ 3 pixels) delineating mitochondrial versus cytoplasmic areas.
Calibrations. We performed empirical calibrations of fluorescence values for fluo-3 AM and rhod-2 AM to be able to compare [Ca 2ϩ ]cyt and [Ca 2ϩ ]mito. Although these are not ratiometric dyes, Ca 2ϩ can be estimated by essentially mapping fluorescence intensity to known Ca 2ϩ levels. Calibrations were performed with ASM cells loaded with either fluo-3 AM or rhod-2 AM (2.5 M) perfused successively with 11 K2EGTA/CaEGTA buffers (free Ca 2ϩ ranging from 0 to 39 M, Ca 2ϩ calibration buffer kit no. 1, Invitrogen). Gray-level values of fluorescence intensities at various settings used with the epifluorescence imaging system and for each Ca 2ϩ concentration buffer were converted to a family of calibration curves as previously described (54, 59, 80 ] mito , human ASM cells were loaded with fluo-3 AM and rhod-2 AM (Fig. 1) . The distribution of fluo-3 AM was diffuse, whereas rhod-2 AM was localized to punctate areas typical of mitochondria. Ca 2ϩ responses were measured in cells that exhibited a fusiform shape with a centrally located nucleus typical of healthy human ASM cells and showing homogenous loading with fluo-3 AM and punctate loading of rhod-2 AM (Fig. 1, A-C) . In some experiments, cells were loaded with rhod-2 and MitoTracker green to confirm that the pattern of rhod-2 staining was restricted to mitochondria (Fig.  1, D-F) . In a second set of experiments, ASM cells were loaded with BODIPY-FL-thapsigargin and then MitoTracker red CMXRos (Fig. 1, G-I) . The pattern of MitoTracker red CMXRos staining was similar to that of rhod-2 and MitoTracker green (not shown). We observed that mitochondria are present in large numbers within human ASM cells, primarily around the nucleus, where they form a dense interconnected network. The SR Ca 2ϩ pumps visualized with BODIPY-FLthapsigargin appeared to be highly localized around the nucleus (Fig. 1G) , where a dense network of mitochondria was also observed (Fig. 1, H and I) . BODIPY-FL-thapsigargin fluorescence was far less intense elsewhere within the cells. Image analysis of 10 ASM cells revealed that the network of mitochondria juxtaposed with the SR Ca 2ϩ pumps was within 40 m of the centroid of the nucleus. These mitochondria were defined as perinuclear for subsequent analyses. Mitochondria located Ͼ50 m from the centroid of the nucleus and within 10 m of the cell membrane were defined as distal for subsequent analyses.
As shown in Fig. 1 , B and E, some weaker rhod-2 AM fluorescence could be observed in the cytosol. Therefore, it was important to verify that the rhod-2 readings within the ROIs did not reflect cytosolic Ca 2ϩ . ASM cells were loaded with MitoTracker green and rhod-2 AM (Fig. 2, A-C) , and ROIs (3 ϫ 3 pixels) used to measure change in rhod-2 AM fluorescence were placed within the mitochondria (identified with MitoTracker green), in the cytosol or near mitochondria where some weaker rhod-2 AM background fluorescence was observed (Fig. 2C) . Transient increases in rhod-2 fluorescence induced by 10 M histamine completely overlapped with regions of MitoTracker green fluorescence (region 1 in Fig.   2C ). In ROIs outside of the mitochondria (Mitotracker green fluorescence), histamine did not induce a rhod-2 fluorescence response (e.g., regions 2 and 3 in Fig. 2C ). These data confirmed that the responses obtained with rhod-2 AM were specific to change in [Ca 2ϩ ] mito and not [Ca 2ϩ ] cyt (Fig. 2D) . To confirm the specificity of our fluorescent imaging, ASM cells were loaded with only MitoTracker green or rhod-2 AM. MitoTracker green-loaded cells excited at 488 nm showed specific fluorescence at 501 nm, corresponding to MitoTracker green, whereas excitation at 568 nm (the rhod-2 AM excitation wavelength) did not show significant (above background) specific fluorescence at 590 nm (Fig. 2, E and F) . Similarly, the excitation of rhod-2 AM-loaded cells with 488 nm (the Mitotracker green excitation wavelength) did not result in any nonspecific fluorescence at 501 nm (above background; Fig.  2G ), whereas excitation at 568 nm resulted in specific fluorescence at 590 nm, corresponding to rhod-2 AM.
In selected experiments, ASM cells were loaded with either fluo-3 AM or rhod-2 AM, and the responses to an agonist obtained for each Ca 2ϩ indicator were compared with those obtained with simultaneous loading of the cells. No differences were found in terms of delays, amplitudes, etc., indicating a lack of interference between the two dyes. The ROIs (3 ϫ 3 pixels) were placed into the cytosol to measure changes in [Ca 2ϩ ] cyt (Fig. 3, A and B) or were placed at the center of well-delineated mitochondrial groups to measure changes in [Ca 2ϩ ] mito (Fig. 3, C and D by a rapid increase in [Ca 2ϩ ] mito (Fig. 3, B and D) . When the ROIs to measure changes in rhod-2 fluorescence were placed within the cytosol, we did not observe any response to histamine stimulation (Fig. 3D) (Fig. 3, B and D) ] mito responses induced by histamine were not significantly different (P Ͼ 0.05; Fig. 4A ). The amplitude of [Ca 2ϩ ] mito in the distal region was slightly lower than for the perinuclear region; however, there was substantially greater variability in the [Ca 2ϩ ] mito responses in the distal regions (Fig. 4A) ] cyt was moderately increased after the exposure to TNF-␣ (ϳ50 nM, P Ͻ 0.05, n ϭ 40; Fig. 7A ). In contrast, basal [Ca 2ϩ ] mito was unaffected by TNF-␣ (Fig. 7, B and C) . Consistent with previous observations (74, 75, 84) , TNF-␣ significantly increased the amplitude of the [Ca 2ϩ ] cyt response to ] cyt was increased by TNF-␣ (ϳ40 -50% of control, P Ͻ 0.05, n ϭ 37; Fig. 8C ). Ru360 or CGP-37157 did not significantly further increase the fall of [Ca 2ϩ ] cyt , which was found to be more variable than for control cells. TNF-␣ decreased the fall of [Ca 2ϩ ] mito from perinuclear regions (ϳ20% of control, P Ͻ 0.05, n ϭ 37; Fig. 8C ), which was, in contrast, significantly increased by CGP-37157 (ϳ40% of control, P Ͻ 0.05, n ϭ 37; Fig. 8C ] mito were not affected by IL-13 (Fig. 9, A-C) . No significant change of the amplitude of the [Ca 2ϩ ] mito response to histamine was observed in the distal or perinuclear regions of the cells exposed to IL-13 (P Ͼ 0.05, n ϭ 20; Fig. 9, B and C, and 10B) ] mito responses was also not significantly changed by IL-13 (P Ͼ 0.05, n ϭ 20). However, the delays observed after the exposure to IL-13 or TNF-␣ were much variable than in control cells. Inhibition of MCU with Ru360 increased the [Ca 2ϩ ] cyt response to histamine, whereas inhibition of mitochondrial NCX with CGP-37157 reduced the effect of IL-13 (ϳ272% and ϳ177% of control, respectively, P Ͻ 0.05, n ϭ 20; Figs. 9A and 10A) . In ASM cells treated with IL-13, Ru360 decrease the amplitude of the [Ca 2ϩ ] mito response to histamine in the distal regions (ϳ46% of control, P Ͻ 0.05, n ϭ 23) and perinuclear regions of the cells (ϳ38% of control, P Ͻ 0.05, n ϭ 23; Figs. 9, B and C, and 10B). CGP-37157 increased the amplitude of the [Ca 2ϩ ] mito response to histamine in the perinuclear regions of the cells treated with IL-13 (ϳ165% of control, P Ͻ 0.05, n ϭ 19; Figs. 9B and 10B). In the distal regions, the effect of CGP-37157 was found to be more variable and overall not significant (Fig. 10B) . The fall of [Ca 2ϩ ] cyt was increased by IL-13 (ϳ50% of control, P Ͻ 0.05, n ϭ 23), whereas the fall of [Ca 2ϩ ] mito was decreased (ϳ40% of control, P Ͻ 0.05, n ϭ 23; Fig. 10C ). Ru360 did not further increase the fall of [Ca 2ϩ ] cyt or [Ca 2ϩ ] mito compared with IL-13-treated cells. In contrast, CGP-37157 significantly increased the fall of [Ca 2ϩ ] mito (ϳ35% of control, P Ͻ 0.05, n ϭ 23) but not the fall of [Ca 2ϩ ] cyt compared with IL-13 alone (Fig. 10C) . 
DISCUSSION
During agonist stimulation, mitochondrial Ca 2ϩ uptake of cytosolic Ca 2ϩ has been described in many cell types (13, 25, 33, 38, 48, 55, 56, 65) . In this regard, spatial localization of mitochondria may play an important role. Mitochondria are often located near the SR or PM, and a common hypothesis is that mitochondria alter SR Ca 2ϩ release and reuptake as well as PM Ca 2ϩ influx/efflux (10, 13, 16, 25, 33, 38, 43, 48, 52, 60, 62, 63, 65, 70) . Inflammation may further modulate some mitochondrial functions (19, 51, 68) and the relationship between mitochondria and the SR (64, 65 ] cyt responses, as predicted by some theoretical models of Ca 2ϩ signaling in smooth muscle cells (66, 67) . Cytosolic Ca 2ϩ is enhanced in airway diseases such as asthma, and it has been proposed that inflammation is a key factor. We and others (2-4, 61, 71, 74, 75, 77, 84) ] cyt regulatory mechanisms may be involved in their interactions with mitochondria. PM NCX, sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA), and SOCE have been found to be affected by both cytokines (26, 72, 74, 84) , which, in turn, may affect [Ca 2ϩ ] mito , but their contributions remain to be determined. Recent studies (13, 68) ] mito in ASM cells treated with TNF-␣, suggesting that MCU was inhibited. An increase of mitochondrial Ca 2ϩ uptake leads to ROS generation and ATP production, and high mitochondrial [Ca 2ϩ ] is detrimental to mitochondrial functions. In our study, it was not clear if after 48 h of exposure to TNF-␣ the MCU is inhibited to prevent a high level of mitochondrial H 2 O 2 or whether TNF-␣ is involved in regulating the energetic demand of the cells. Potential downstream genomic effects also remain to be explored, especially in ASM.
Mitochondrial Ca 2ϩ transport is activated by large [Ca 2ϩ ] cyt changes in the micromolar range (32, 48, 64, 69) . Given that global [Ca 2ϩ ] cyt elevations in most tissues are only in the low micromolar range, local [Ca 2ϩ ] cyt levels in the vicinity of the SR or PM must reach high enough levels to activate mitochondrial Ca 2ϩ buffering (27, 53, 56, 57) . A recent study (27) ] mito , whereas inhibition of MCU with Ru360 decreased [Ca 2ϩ ] mito . However, an interesting and novel observation in our study was the differential roles of mitochondrial NCX versus MCU in the perinuclear versus distal regions of ASM cells. In the distal regions, CGP-37157 had no significant effect, whereas Ru360 consistently decreased [Ca 2ϩ ] mito . Here, based on the typical fusiform shape of ASM cells, we propose that the distal mitochondria may be close to the PM and thus affected by and, in turn, influence Ca 2ϩ influx. Accordingly, a role for the uniporter in buffering Ca 2ϩ influx is likely to take precedence in these cellular areas. Mitochondrial Ca 2ϩ uptake is also associated with increased ATP production. As the distal area of ASM cells is primarily associated with the contractile apparatus, the energetic demand might be higher than in the perinuclear area and favor mitochondrial Ca 2ϩ uptake. In TNF-␣-exposed cells, Ru360 did not further decrease [Ca 2ϩ ] mito , suggesting an inhibitory effect of TNF-␣ on MCU. These differences between the two regions remain to be further explored in the context of cytokine effects on energy availability for the contractile apparatus in the distal areas of ASM cells versus other effects, such as in the SR or nuclear Ca 2ϩ reuptake in the perinuclear area.
Impaired mitochondrial Ca 2ϩ buffering has been reported to enhance [Ca 2ϩ ] cyt release in different cell types (8, 10, 14, 62) . The regulation of [Ca 2ϩ ] cyt by mitochondria may reflect the Ca 2ϩ buffering capacity (either global or localized) of the mitochondria or/and by indirect effects of some mitochondrial function. The physical proximity of mitochondria to the SR had led several recent studies (11, 34, 36, 66) to examine possible functional interactions between the SR and mitochondria. A common hypothesis is that the mitochondria alter SR Ca 2ϩ refilling by competing with SERCA pumps for the removal of cytosolic Ca 2ϩ (49) . In smooth muscle (as in other muscles), SERCA is the mechanism for filling the SR, with two (6, 11, 12, 14, 15, 34, 36) . Here, the effects appear to be cell type specific, with both inhibition and promotion of SR Ca 2ϩ release being reported (6, 11, 12, 15 Recently, the molecular identities of MCU [MCU/mitochondrial Ca 2ϩ uptake 1 (MICU1)] and NCX (also called NCLX) (7, 21, 22, 47) have been uncovered, and the development of molecular tools may help us to better understand the relation between MCU and NCX with other established Ca 2ϩ regulatory mechanisms. In this regard, studies examining MICU1 and NCX have relied on the specificity of Ru360 and CGP-37157 (18) . Accordingly, these pharmacological inhibitors form an appropriate first step toward examining [Ca 2ϩ ] mito in primary cells such as human ASM, which tend to be recalcitrant to RNA interference approaches targeting MICU1 and NCX (pilot studies).
In addition to SR Ca 2ϩ release and reuptake, PM Ca 2ϩ influx/efflux is a major component of [Ca 2ϩ ] cyt regulation in ASM. We (5, 75, 84) have previously demonstrated the importance of SOCE in ASM, triggered after SR Ca 2ϩ depletion. It is important to recognize that the extent of Ca 2ϩ influx via SOCE is not simply dependent on local PM Ca 2ϩ gradients but is regulated by the state of SR repletion, [Ca 2ϩ ] cyt -dependent fast and slow inactivation, and even by other intracellular signaling cascades (e.g., diacylglycerol) (50) . There is now evidence in non-ASM tissues that mitochondria can also influence SOCE (35, 44, 50 ] mito . We (84) have previously shown that TNF-␣ increases SOCE. Therefore, we would have expected [Ca 2ϩ ] mito to be enhanced in the presence of TNF-␣, allowing SOCE to be maintained. The reasons underlying this discrepancy are not clear but may involve cytokine-induced dysregulation of MCU itself.
In the present study, we found that the effects of TNF-␣ versus IL-13 on [Ca 2ϩ ] mito were substantially different, especially depending on the location of the mitochondria. The functional relevance of these differences remains to be determined. However, it is possible that although both cytokines, which are important in asthma, can robustly enhance [Ca 2ϩ ] cyt , the mechanisms by which this is achieved may differ, including mitochondrial Ca 2ϩ regulation. Overall, the present study demonstrates that mitochondria buffer [Ca 2ϩ ] cyt in human ASM cells and contribute to the modulation of [Ca 2ϩ ] cyt . Considering the importance of [Ca 2ϩ ] cyt regulatory mechanisms in enhancing [Ca 2ϩ ] cyt under conditions such as inflammation (relevant to diseases such as asthma), our study underlines the emerging importance of mitochondria, especially MCU, in inflammatory airway disease.
